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Abstract
About 1/3rd of all women diagnosed with subfertility have a tubo-peritoneal factor contri‐
buting to their condition. Most of these alterations in tubo-ovarian function come from
post-inflammatory damage inflicted after a pelvic or sexually transmitted infection. Sal‐
pingitis occurs in an estimated 15% of reproductive-age women, and 2.5% of all women
become infertile as a result of salpingitis by age 35. Predominant organisms today include
those from the Chamydia species and the infection causes minimal to no symptoms –
leading to chronic infection and consequently more damage. Again, a large proportion of
patients suffering from pelvic infection contributing to their subfertility are undiagnosed
to be having an infection. Chronic inflammation of the cervix and endometrium, altera‐
tions in reproductive tract secretions, induction of immune mediators that interfere with
gamete or embryo physiology, and structural disorders such as intrauterine synechiae all
contribute to female infertility. Infection is also a major factor in male subfertility, second
only to abnormal semen parameters. Epididymal or ductal obstruction, testicular damage
from orchitis, development of anti-sperm antibodies, etc are all possible mechanisms by
which infection can affect male fertility.
Keywords: Infertility, Infection, pelvic inflammatory disease, salpingitis, epididymo-or‐
chitis, antisperm antibodies
1. Introduction
The association between infection and infertility has been long known. Of all causes of female
Infertility, tubal or peritoneal factors amount to about 30-40. The infections that lead to
asymptomatic infections are more damaging as lack of symptoms prevents a patient from
seeking timely medical intervention and consequently chronic damage to pelvic organs.
Indeed, timely management of sexually transmitted or other infections goes a long way in
preventing damage, disability, chronic pelvic pain, altered tubo-ovarian relationship and
consequently helps in maintaining fertility.
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Tubal and peritoneal pathology is among the most common causes of infertility and the
primary diagnosis in approximately 30-35% of infertile couples. A history of pelvic inflam‐
matory disease (PID), septic abortion, ruptured appendix, tubal surgery, or ectopic pregnancy
suggests the possibility of tubal damage. PID is unquestionably the major cause of tubal factor
infertility and ectopic pregnancies. Classic studies in women with PID diagnosed by laparo‐
scopy have revealed that the risk of subsequent tubal infertility increases with the number and
severity of pelvic infections; overall, the incidence is approximately 10-12% after one episode,
23-35% after two, and 54-75% after three episodes of acute PID.[1] The most frequent causes
for pelvic infections are sexually transmitted pathogens and intrauterine manipulations like
curettage, evacuation, etc.
2. Epidemiology
Approximately 35% of women with an infertility problem are afflicted with post-inflammatory
changes of the oviduct or surrounding peritoneum that interfere with tubo-ovarian function.
Most of these alterations result from infection. Salpingitis occurs in an estimated 15% of
reproductive-age women, and 2.5% of all women become infertile as a result of salpingitis by
age 35.[2] Because in most cases, especially those caused by Chlamydia trachomatis, signs and
symptoms are often minimal or non-existent, the actual percentage of women with upper
genital tract infections is probably underestimated.
Unfortunately, the impact of infectious sequelae on human reproduction continues to increase
as a consequence of sexual promiscuity and the popularity of non-barrier methods of contra‐
ception. C. trachomatis and gonorrheal infections, as well as mixed anaerobic infections, are the
most prevalent causes of upper genital tract infections resulting in pelvic inflammatory disease
(PID). Bacterial vaginosis, Trichomonas vaginalis, and Candida albicans are the most prevalent
bacterial, protozoan, and fungal causes of lower genital tract infections. Although gonorrheal
infections have been on the decline in the last decade, chlamydial infections of the male and
female genital tract continue to be an increasing problem, and C. trachomatis is the major cause
of tubal factor infertility.[3] C. trachomatis is usually recovered three to five times more
frequently than Neisseria gonorrhoeae from the reproductive tracts of infected individuals.
Women are twice as likely as men to acquire gonorrhea or Chlamydia during a single act of
unprotected intercourse with an infected partner. Many newly infected women have no
symptoms and so do not seek medical intervention and continue to spread the infection to
other sexual partners. An estimated 10% to 20% of untreated women with endocervical
gonorrhea or chlamydial infection eventually develop salpingitis.[4] Scholes et al[5] recom‐
mended routine testing of sexually active women to prevent sequelae like pelvic inflammatory
disease and consequently infertility. Despite the current focus on sexually transmitted diseases
(STDs), infertility may also follow blood-borne infections such as tuberculosis, mixed aerobic
and anaerobic infections of other pelvic sites, inflammatory complications of surgical trauma,
post-abortal and puerperal sepsis, and appendicular rupture.
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3. Infections and male infertility
Acute and chronic genital tract infections are well-known causes of infertility in men (Table
1). Episodes of acute orchitis or epididymitis may result in permanent damage to the testis or
to obstruction in the efferent ejaculatory ducts. C. trachomatis causes approximately 50% of
epididymitis in sexually active men under age 35. Unilateral epididymal obstruction is seldom
diagnosed, and its effect on fertility is largely unknown. However, 80% of men with unilateral
ductal obstruction have antibodies to sperm, a potential cause of male infertility.[6] Appro‐
priate assessment of a semen sample including tests like presence of seminal Fructose, neutral
alpha-glucosidase and pH go a long way in differentiating between obstructive and non-
obstructive azoospermia.
Orchitis mumps, tuberculosis, syphilis, pancreatitis
Epididymitis gonorrhea, tuberculosis, chlamydiae, ureaplasmas,Pseudomonas, coliform, and other bacterialinfections
Seminal vesiculitis tuberculosis, trichomoniasis, other bacteria
Urethritis gonorrhea, chlamydiae, ureaplasmas, trichomoniasis
Table 1. Male Genital Tract Infections That May Cause Infertility
Most men do not develop antibodies to their own spermatozoa because the male genital tract
is essentially a closed tube, and sperm are isolated from the immune system. Genital tract
infections, even those without symptoms, can weaken this barrier, leading to sperm leakage
and the influx of immunologically competent cells. Genital tract infections are a major cause
of anti-sperm antibody formation in men.[7] Similarly, genital tract infections and anti-sperm
antibody formation in men can lead to immune-mediated infertility in women.[8]
Mumps orchitis is a well-known testicular infection resulting in damage to the germinal
epithelium. Systemic infections, whether bacterial or viral, may also cause depression of sperm
production for variable periods. Between 2 and 6 months may be required for normal seminal
cytology to reappear after a severe febrile illness. Urethral stricture is an occasional compli‐
cation of untreated gonorrhea. Although the stricture does not in itself interfere with sperm
motility, it may cause recurring urinary tract infection or prostatitis and epididymitis.
The fertility of a couple may be impaired if the man has a chronic bacterial prostatitis. Chronic
prostatitis is presumed to be caused by a pathogenic organism and in most cases is associated
with leukocytes in the semen. The prevalence of leukocytospermia among male infertility
patients is about 10% to 20%. Although the exact role of WBCs in semen and its importance
with respect to fertility is not clearly elucidated, there is some evidence that treating such
patients with long term antibiotics does have a favourable impact on the semen parameters.[9]
According to a study the presence in semen of counts more than 10,000 colony-forming units/
ml had a negative effect on IVF pregnancy rates when E. coli, Proteus, or S. aureus organisms
were isolated.[10] Again, there is some evidence that the occurrence of leucocytes in semen
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yields abnormal sperm function tests, possibly because of the damaging effects of free radicles
of WBCs to the sperms in their journey through the epididymis.[11] There is also substantial
evidence that infection contributes to the development of sperm antibodies. Sperm antibodies
have been detected in 48% of men with culture-positive asymptomatic infections, 47% of men
with a history of urethritis or prostatitis, and in only 5% of men with no infection and a normal
semen analysis.
The presence of IgA antibodies was associated with reduced fertility.[12] High concentrations
of sperm antibodies can interfere with fertility by several mechanisms. Antibodies on sperm
heads or tails may cause sperm to agglutinate. Tail-bound antibodies also interfere with sperm
motility. Antibodies anywhere on spermatozoa can lead to sperm phagocytosis through
binding to Fc or complement receptors on phagocytic cells. Similarly, antibody-bound sperm
react with cervical mucus leading to sperm immobilization and expulsion from the female
genital tract. Antibodies on sperm can interfere with sperm binding and penetration of the
oocyte.[13] Similar to the situation in women, C. trachomatis infection of the male genital tract
is often asymptomatic and therefore may persist for a long time. One study using PCR analysis
of semen specimens suggested that an asymptomatic unsuspected C. trachomatis male genital
tract infection may be the cause of previously unexplained infertility.[14] In response to a
persistent asymptomatic chlamydial infection and HSP60 production, γδ T cells may be
induced in the male genital tract; γδ T cells are capable of releasing proinflammatory cytokines
and could therefore initiate an antisperm immune response within the genital tract.
4. Infections and female infertility
4.1. Pelvic inflammatory disease
PID is a common but vaguely defined complex of signs and symptoms resulting from the
spread of pathogenic microorganisms from the vagina and endocervix to the uterus, body of
the endometrium, and fallopian tubes. PID can also follow aseptic induced abortion or as a
post-partum infection. C.Trachomatis salpingitis can be seen in as many as 15% patients who
undergo an induced abortion. PID has reached epidemic proportions and according to the
CDC, the cost of PID measured in lost earnings and money spent for health services was
estimated at $4.2 billion in 1990.[15] According to a Swedish study[16] tubal infertility occurs
in approximately 11% of women who have one episode, in 23% of women who have two
episodes, and in 54% of women who have three or more episodes of salpingitis. (Table 2)
As could be seen from Table 2, they found that tubal infertility is directly related to a number
of factors present during the initial episode of salpingitis, which include (besides the number
of episodes) the initial severity of tubal inflammation, the organisms responsible, and the
occurrence of a subsequent ectopic pregnancy. The best predictor of subsequent infertility is
the degree of tubal inflammation observed through the laparoscope during the acute phase.
Women with a pelvic abscess have had the highest (85% to 90%) rate of subsequent infertility.[17]
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Clinical Findings Tubal Occlusion
Degree of acute inflammation at laparoscopy*
Mild 6%
Moderate 13%
Severe 30%
Number of episodes of salpingitis*
One 11%
Two 23%
Three or more 54%
Type of salpingitis†
Gonococcal 9%
Nongonococccal 16%
* Westrom L: Incidence, prevalence and trends of acute pelvic inflammatory disease and
the consequences of industrialized countries. Am J ObstetGynecol 135:880, 1980.
† Westrom L: Effects of acute pelvic inflammatory disease on infertility. Am J ObstetGy‐
necol 121:707, 1975
Table 2. Factors Influencing the Frequency of Tubal Occlusion after Salpingitis
Prompt recognition and vigorous treatment reduce subsequent severe complications of
salpingo-oophoritis, such as generalized pelvic peritonitis, abscess formation, and adnexal
destruction. However, many patients of PID are often asymptomatic. Approximately 60% to
80% of women with acute salpingitis have a normal temperature or no white blood cell
elevation. This finding correlates with the observation that most women with tubal infertility
have never been treated for a recognized episode of salpingitis. Epidemiologic studies support
the concept of silent PID wherein a strong link exists between serum antibodies to C. tracho‐
matis and tubal factor infertility or ectopic pregnancy in patients without a history of clinical
PID.[18]
4.1.1. Treatment strategies
Prompt treatment is the key in adequate eradication of the responsible organism(s) and
preventing long term sequelae like hydrosalpinx, infertility, ectopic pregnancy, and chronic
pelvic pain. If the patients with mild symptoms had only cervicitis or endometritis and not
salpingitis, prompt treatment before the onset of salpingitis would have a major impact on
preventing tubal occlusion. Failure to use doxycycline or azithromycin to inhibit C. trachoma‐
tis may contribute to chronic salpingitis.[19] Approximately one half of the women with an
ectopic pregnancy have grossly visible tubal damage or a partial occlusion of the tubes. About
7% to 10% of pregnancies that occur after an episode of salpingitis are in an ectopic location,
and women with salpingitis have a 10-fold higher rate of ectopic pregnancy than does the
general population. Approximately 40% of women who have had an ectopic pregnancy are
not able to achieve an intrauterine pregnancy subsequently.[20]
Infection and Infertility
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4.1.2. PID and HIV
A population-based study of fertility in women with human immunodeficiency virus type 1
(HIV-1) infection in Uganda demonstrated that fertility is greatly reduced in HIV-1-infected
women because of a lower rate of conception and increased rates of miscarriage and stillbirth.
Numerous epidemiologic studies have demonstrated that there is a synergy among bacterial
and viral STDs. Bacterial STDs have been implicated in the enhancement of HIV transmission.
Conversely, the immunosuppression caused by HIV worsens the clinical course of other STDs.
The low prevalence and incidence of pregnancy among HIV-infected women could reflect pre-
existing tubal factor infertility and higher clinical and subclinical fetal losses resulting from
HIV-1 infection.[21]
Pelvic inflammatory disease that is non-tubercular in origin can be divided into gonococcal,
chlamydial, and nongonococcal-nonchlamydial disease based on the results of endocervical
or peritoneal fluid cultures.
4.2. Gonococcal infection
Gonococcal PID still a major cause of infertility in women in developing Asian and African
countries.[22] The bacterium N. Gonorrhea (Figure 1) elicits a pyogenic, inflammatory reaction
characterised by purulent exudates. As the organisms replicate, the ensuing local tissue
damage diminishes the oxidation-reduction potential of the environment – this explains why
it is common to discover co-existing pathogens.The recovery of N. gonorrhoeae from tubal or
peritoneal fluid in acute salpingitis patients with endocervical gonorrhea ranges from 6% to
70%. Approximately one third of patients have N. gonorrhoeae as a sole isolate, one third have
N. gonorrhoeae plus a mixture of aerobic and anaerobic bacteria, and one third have a mixture
of aerobic and anaerobic bacteria in the cul-de-sac only.[23]
Figure 1. Neisseria Gonorrhea bacteria
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N. gonorrhoeae secretes a toxin that can destroy cilia of adjacent cells in the tubal epithelium.
Not only is the organism difficult to isolate from pus, but the recovery of N. gonorrhoeaedepends
on the stage of infection. The gonococcus is most frequently isolated within 2 days of the onset
of symptoms and is rarely isolated if symptoms are present for 7 or more days.[24] Most
symptomatic gonococcal PID cases have their onset during or just after the menses. These
observations are consistent with the view that the gonococcus initiates the infection and, if the
infection is not promptly treated, sets the stage for a mixed aerobic-anaerobic infection,
involving pathogens that originate in the cervix and vagina.
4.3. Chlamydial infection
C. trachomatis is an intracellular bacterium that proliferates in columnar epithelial cells, where
it remains protected from host immune defences by a cell membrane. It takes a longer time for
C. trachomatis to divide (24 to 48 hours) than for classic bacteria (1 to 4 hours). There is a
characteristically long time between infection and the onset of symptoms among women with
C. trachomatis, and only mild symptoms usually occur. Widespread or systemic symptoms are
unusual, although infection of the endosalpinx can produce generalized peritonitis by
contiguous spread, including perihepatitis (Fitz-Hugh-Curtis syndrome).
Chlamydia appears to be a particularly important organism in infertility. There are multiple
published reports in which women with tubal infertility have a 25% to 70% higher incidence
of C. trachomatis antibody than do infertile women with normal tubes.[25] In many developed
countries, C. trachomatis infections are now clearly the leading cause of tubal infertility. C.
trachomatis causes the same spectrum of disease (e.g. urethritis, cervicitis, endometritis,
salpingitis) as the gonococcus. C. trachomatis causes salpingitis more frequently than the
gonococcus. Also, the degree of acute tubal damage among women with chlamydial infection
equals or exceeds that observed with gonococcal infection. Women with chlamydial infection
may have gonorrhea and vice versa.
C. trachomatis is inhibited in vitro by doxycycline and azithromycin but not by cephalosporins.
Women with salpingitis should be treated with tetracyclines or other antibiotics that inhibit
C. trachomatis, because cephalosporin therapy alone does not eradicate C. trachomatis.[26] Lack
of symptoms ensures that the undetected C. trachomatis are able to ascend from the lower to
the upper genital tract, evade the host's immune response and persist for long periods of time.
Figure 2 shows the life cycle of Chlamydia infection. Extracellular C. trachomatis elementary
bodies (EB) infect epithelial cells. Within the cell, the EBs convert to reticulate bodies (RB),
which replicate by binary fission. The RBs then convert back to EBs that are released from the
cell and infect other epithelial cells. The presence of extracellular EBs activates the host's
immune response, and interferon-γ is released. The interferon blocks RB replication, resulting
in the formation of large, aberrant RBs. However, the RBs remain viable, and when the
extracellular infection is cleared and interferon-γ is no longer present, normal RB replication
resumes. These repeated cycles of replication and immune activation followed by chlamydial
persistence in epithelial cells of the fallopian tube eventually lead to scar formation and tubal
occlusion.[27] As has been already discussed, Witkin and co-workers found that women
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previously infected with chlamydia – detected by circulating systemic humoral immunity to
HSP 60 had unfavourable outcomes with IVF.[18]
4.4. Nongonococcal-nonchlamydial infection
Approximately 1/4th of women with PID have a nongonococcal-nonchlamydial cause.[28]
Patients with nongonococcal PID have the onset of pain distributed evenly throughout the
cycle and less frequently associated with menses. There is less fever, vaginal discharge, and
liver tenderness than with gonococcal PID. Despite these differences, the clinical presentation
does not adequately distinguish between the two, and reliance on culture is necessary. There
may be a critical number of organisms needed to breach the normally present protective host
defence mechanisms and lead to infection. There is probably a continuum from bacterial
vaginosis to endometritis and salpingitis, because women with bacterial vaginosis are
significantly more likely to be diagnosed with PID.[29] The substantial isolation rate of bacteria
other than gonococci or C. trachomatis from tubal fluid of these PID patients has shown that
bacterial vaginosis organisms can cause acute salpingitis without antecedent chlamydial or
gonococcal infection. Peritoneal or tubal cultures have yielded a mixed aerobic and anaerobic
flora in 35% to 50% of patients, anaerobes alone in 15%, and aerobes alone in approximately
30% to 40% of patients. Between 4% and 17% of women with PID have had M. hominis, and
2% to 20%, have had U. urealyticum recovered from the fallopian tubes.[30]
4.5. Genital mycoplasmas and unexplained infertility
Mycoplasmas share characteristics of bacteria (they reproduce on cell-free media) and viruses
(they have no cell wall and are 100 to 300 μm in diameter). Two species of mycoplasmas have
Figure 2. Effect of interferon-γ on the life cycle of Chlamydia trachomatis.
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been commonly isolated from the female and male reproductive tracts: M. hominis and the
heterogeneous group known collectively as T mycoplasma (so named for their characteristic
“tiny” colonies). A distinctive property of the T strains is their ability to hydrolyze urea, and
they have been named U. urealyticum. A third species, Mycoplasma genitalium has been isolated
from the urethra of men and is believed to be a cause of urethritis.
Genital mycoplasmas may be of etiologic importance in nonspecific urethritis, cervicitis, and
vaginitis; some cases of acute salpingitis; fever after abortions; chorioamnionitis; and puerperal
infections. However, the causal role of genital mycoplasmas in infertility is still unresolved.
4.6. Genital tuberculosis
Tuberculosis continues to be endemic in many poor parts of the world like Latin America and
Asia. The incidence of pelvic tuberculosis is difficult to assess as many patients are asympto‐
matic, therefore the disease often comes to light only incidentally during the course of
investigation for a gynecological complaint. Schaefer[31] as early as in 1976 reported that 4-12%
of women dying from pulmonary tuberculosis manifest evidence of genital involvement. He
further mentioned that 5-10% of infertile women suffer from tuberculosis. The incidence of
tuberculosis amongst women with infertility is believed to be higher in the third world
countries.
The causative agent is Mycobacterium tuberculosis (95%) but in 5% cases it is Mycobacterium
bovis. Genital tuberculosis almost always occurs secondary to a primary focus elsewhere, the
commonest site being the lungs, but rarely from the kidneys, joints, GIT or as a part of a
generalized military infection. The mode of spread is hematogenous or lymphatic and rarely
from direct contiguity with an intra-abdominal organ or affected peritoneum. The fallopian
tubes are affected first followed by subsequent dissemination to other genital organs – this
explains the bilateral tendency of the disease. Primary genital tuberculosis is rare and possibly
originates from the semen or saliva of a positive sexual partner. Tuberculosis of the cervix is
present in about 5% of cases.
The leading presenting complaints in women suffering from genital tuberculosis include
infertility, menstrual problems, abdominal pain, vaginal discharge and rarely genital fistulas
or mass per abdomen. Sometimes general symptoms of low grade temperature, weight loss
and fatigue may raise the suspicion of hitherto unsuspected tuberculosis. Classis feature is
failure of fever to subside in spite of broad spectrum antibiotics. Therefore, a clinical course
that is refractory to antibiotic therapy for the usual pelvic inflammatory disease should alert
the physician to the possibility of tuberculosis. Pelvic examination may reveal findings like
thickened adnexa which may be tender. However it may be completely normal.
Infertility is an important presenting symptom. In fact in 35-60% cases it is the only complaint.
About 75% present with primary infertility and 25% give history of previous conception. These
patients may or may not give a history of contact with a person suffering from pulmonary
tuberculosis.
Diagnosing tuberculosis still remains a challenge. This is due to a wide variety of clinical
presentation and lack of diagnostic tests with a good positive predictive and negative predic‐
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tive value. A single, reliable, convenient, economical test that has a good degree of sensitivity
and specificity is yet to be discovered. Diagnosis still remains subjective, and is done usually
at the time of laparoscopy done for evaluating infertility or chronic pelvic pain. Pathognomic
sign of appearance of small tubercles all over the peritoneum that represent caseating granu‐
lomas is seen only rarely. Other findings include appearance of tubo-ovarian masses with
varying degree of intra-pelvic adhesions, bead like growths or rigid lead-pipe appearance of
fallopian tubes, hydrosalpingx and military white tubercles on the serosa of the uterus.
Samples can be taken for acid-fast bacilli staining (Figure 3) or culture. However both methods
have low sensitivity. Polymerase chain reaction is highly sensitive, but may yield false
positives due to contamination of sample from air or water contaminants. Mantoux test has
limited utility now.
Figure 3. Typical tubercular lesion in histo-pathology
4.6.1. Treatment of tuberculosis
Extra pulmonary tuberculosis usually requires 8 to 10 months of continuous treatment
particularly in developing countries to prevent emergence of multi-drug resistant tuberculosis,
which is very common if treatment is given for a short period and stopped. Also, premature
discontinuation of treatment may render the organisms resistant and lead to re-emergence of
infection with much more severity. The therapeutic phase is divided into an intensive phase
of about 2 to 4 months and continuation phase of 4 to 6 months. The two drugs used throughout
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the treatment period are usually rifampicin (10 mg/kg/day, not exceeding 600 mg/d) and
isoniazid (5 mg/kg/day not exceeding 300 mg). In the past the third drug used during the initial
2-4 months was Ethambutol (5-25 mg/kg/day not to exceed 2.5 gm/day) but now pyrazinamide
(15-30 mg/kg/day, not to exceed 2.5 gm/day) is preferred because it does not have the ocular
toxicity which is seen with ethambutol. Rifampicin is safe in pregnancy.[32] Most of these
drugs are hepatotoxic and have various side effects, these have to be watched for. Surgery for
the management of tuberculosis is not preferred, and reserved for special situations like
persistence of an adnexal mass in spite of anti-tubercular treatment or irresponsiveness of the
infection to anti-tubercular therapy.
5. Pathogenesis of PID
In gonococcal and chlamydial salpingitis, the microorganisms ascend by surface extension
from the lower genital tract through the cervical canal by way of the endometrium to the
fallopian tubes (Figure 4A). There can be adhesion of the mucosal folds, destruction of cilia,
occlusion of the infundibulum, and production of a pyosalpinx. The gonococcal infection may
spread beyond the endosalpinx, with possible focal abscess formation and perisalpingitis. In
some cases of nongonococcal salpingitis, particularly with M. hominis,[33] the pathogens may
enter through lesions in the cervix or endometrium and spread to the parametria and tubes
through lymphatics and blood vessels (Fig. 4B). The inflammatory swelling that affects the
parametria and the tubes is more pronounced than in gonococcal salpingitis, but the endosal‐
pinx is usually intact.
Figure 4. Pathogenesis of pelvic inflammatory disease: Schematic drawings of pathways by which genital tract infec‐
tions spread. A. Direct spread by extension along luminal surfaces is characteristic of gonococcal and chlamydial infec‐
tion. B. Nongonococcal bacterial and genital mycoplasma infections probably spread to the parametria and fallopian
tubes primarily through lymphatics and blood vessels.
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The sequelae of PID that are responsible for infertility include chronic interstitial salpingitis,
hydrosalpinx, salpingitis isthmicanodosa, and periadnexal adhesions. Infertility may also
occur because of abnormal secretory, ciliary, and peristaltic function of the fallopian tube. The
postulated interrelationships of STDs and endogenous organisms in the pathogenesis of tubal
infertility secondary to PID are depicted in Figure 5.[34]
Figure 5. Postulated interactions of sexually transmitted microorganisms with endogenous lower genital tract micro‐
flora in the pathogenesis of pelvic inflammatory disease and tubal factor infertility.(Adapted from Sweet RL, Gibbs RS:
Infectious Diseases of the Female Genital Tract, p 399. 3rd ed. Baltimore: Williams & Wilkins, 1995.)
6. Treatment of PID
There is controversy over the issue of outpatient versus inpatient treatment of patients with
acute salpingitis. For economic and logistical reasons, most women are treated on an outpatient
basis. The decision for hospitalization is usually based on the clinical severity of the illness,
although criteria vary. It seems reasonable to treat major pathogens such as N. gonorrhoeae and
C. trachomatis in every patient. An antibiotic regimen that takes into account the polymicrobial
nature of the cause of acute salpingitis must be used. However, after treatment with different
antibiotics, similar infertility rates have been found.[35] Women treated after 3 or more days
of symptoms had significantly more infertility than those treated earlier.[36] Better recognition
and treatment of cervicitis and endometritis before salpingitis develops is even more important
in the prevention of infertility than the treatment of salpingitis per se. Recommended treatment
schedules for uncomplicated salpingitis are shown as below:
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For acute salpingitis
Parenteral Regimen A
Cefotetan 2 g, IV every 12 hours,
or
Cefoxitin, 2 g, IV every 6 hours,
plus
Doxycycline, 100 mg, IV or orally every 12 hours
Parenteral Regimen B
Clindamycin, 900 mg, IV every 8 hours,
plus
Gentamicin loading dose IV or IM (2 mg/kg of body weight), followed by a maintenance dose
(1.5 mg/kg) every 8 hours. Single daily dosing may be substituted.
Regimen A
Ofloxacin, 400 mg, orally twice each day for 14 days,
plus
Metronidazole, 500 mg, orally twice each day for 14 days.
Regimen B
Ceftriaxone, 250 mg, IM once,
or
Cefoxitin, 2 g, IM plus Probenecid, 1 g, orally in a single dose concurrently
once,
or
Other parenteral third-generation cephalosporin (e.g., ceftizoxime, cefotaxime),
plus
Doxycycline, 100 mg, orally twice each day for 14 days. (Include this regimen with one of the
above regimens.)
(Centers for Disease Control and Prevention: 1998 Guidelines for treatment of sexually
transmitted diseases. MMWR Morb Mortal Wkly Rep 1998;47(RR1):82–82.)
Patients with suspected abscesses or severe illness that may indicate the presence of organisms
other than gonococci or chlamydiae should be hospitalized. Recommended treatment regi‐
mens inhibit not only N. gonorrhoeae and C. trachomatis but also a wide variety of aerobic and
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anaerobic bacteria. For instance, parenteral clindamycin is effective against C. trachomatis and
anaerobes.
The concomitant use of steroids with antibiotics has been thought to reduce the sequelae of
salpingitis, but in a prospective study, Falk [77] could show no beneficial effect as judged by
hysterosalpingography findings or subsequent laparotomy. Prevention of PID recurrence and
its adverse effects on fertility also requires treatment of asymptomatic male sexual partners.In
patients with postinflammatory tubal disease, pregnancy outcome has been correlated with
the presence or absence of fallopian tube rugaeon hysterosalpingograms. Pregnancy occurred
in 61% of patients with moderate to excellent rugal patterns, whereas only 7% of patients with
no demonstrable rugae conceived postoperatively.[38]
Today and in the foreseeable future, assisted reproductive technologies (ART), endoscopic
surgery, and microsurgery have an important place in the management of infertility that
results from tubal disease. There are some tubal causes of infertility for which surgery can offer
little or no chance of success, such as after severe bilateral hydrosalpinx, multisite tubal
obstruction, or in patients with extensive and dense pelvic adhesions. At the other end of the
spectrum are patients who can achieve a 50% to 65% intrauterine pregnancy rate after
microsurgical or laparoscopic adhesiolysis when the fimbriae are spared from disease and a
male factor is not encountered.[39] In choosing between IVF and tubal surgery, the physician
must compare success rates (which can are best defined by the birth of a live baby) and take
into account the patient's age, presence of a male subfertility factor, the personal priorities of
the couple, and the availability of expertise.
7. Early treatment and fertility preservation
The best prevention is to detect and treat early-stage asymptomatic and symptomatic infec‐
tions. This can be achieved by the screening of all sexually active reproductive age women and
by educating clinicians and patients on the importance of this testing. The importance of
practicing safe sex methods cannot be over emphasized in public. Scholes et al found a 60%
reduction in salpingitis prevalence rates when the population was screened for C.trachomatis
infections compared to when they were not.5
With the advent of modern DNA amplification tests like Polymerase Chain Reaction (PCR)
available very sensitive and specific testing on microbes can be done in a matter of hours. This
obviates the need of many organisms as is the case with conventional cultures. Also, the newer
tests are also more specific yielding a higher positive predictive value thus avoiding unnec‐
essary treatments. Microbes like C. trachomatis[40], T. vaginalis[41], and N. gonorrhoeae[42] can
be detected in samples obtained from the vaginal introitus, and there is no longer a requirement
for a speculum examination. There have been efforts to make chlamydial and gonococcal
vaccines, but not met much success.
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8. Conclusion
The best hope for reducing the incidence of infertility related to infection lies in prevention
and early detection and treatment of newly acquired asymptomatic or mildly symptomatic
infections. The importance for the preservation of future fertility of avoiding high-risk sexual
behaviour and the mandatory use of condoms must be stressed. Concomitantly, there must
be an increased awareness by health care providers and consumers of the need for intensive
screening using the latest and most effective molecular techniques followed by early effective
treatment if positive.
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